Holen Sie sich die Stockscreener-App
250.49
2.82%
6.88
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt WST?
Forum
Prognose
Aktiensplit
Dividendenhistorie
West Pharmaceutical Services Inc Aktie (WST) Neueste Nachrichten
West Pharmaceutical Services (WST): Barclays Lowers Price Target - GuruFocus
Stephens Cuts Price Target on West Pharmaceutical Services to $320 From $350, Maintains Overweight Rating - marketscreener.com
West Pharmaceutical Services, Inc. (NYSE:WST) Q4 2025 Earnings Call Transcript - Insider Monkey
West Pharmaceutical Services Q4 Earnings Call Highlights - Yahoo Finance
West Pharmaceutical targets 5%–7% organic revenue growth for 2026 as HVP demand accelerates - MSN
West Pharma forecasts 2026 profit above estimates on strong demand for drug components - 104.1 WIKY
Earnings call transcript: West Pharmaceutical Services Q4 2025 earnings beat expectations - Investing.com Canada
West Pharmaceutical Services (WST) Is Up 5.2% After Strong 2025 Results And 2026 Organic Growth Outlook - Yahoo Finance
West Pharmaceutical Q4 2025 slides: Revenue up 7.5%, EPS exceeds expectations - Investing.com Nigeria
West Pharmaceutical Services (NYSE:WST) Issues Quarterly Earnings Results, Beats Expectations By $0.21 EPS - MarketBeat
West Pharmaceutical Services's (NYSE:WST) Q4 CY2025: Beats On Revenue, Stock Soars - Finviz
WST's Q4 Earnings & Sales Beat, SmartDose Sale by Mid-2026, Stock Up - Finviz
Iron Mountain Projects Double-Digit Growth in 2026 - Investing.com
West Pharmaceutical Q4 2025 slides: Revenue up 7.5%, EPS exceeds expectations By Investing.com - Investing.com India
West Pharmaceutical (WST) Reports Q4 Earnings: What Key Metrics Have to Say - Yahoo Finance
West Pharmaceutical Services (NYSE:WST) Issues FY 2026 Earnings Guidance - MarketBeat
In the latest conference call, West Pharmaceutical Services Inc executives noted that although demand for GLP-1 drugs is showing strong growth momentum in 2025, the growth pace is expected to slow down in 2026. - Bitget
West Pharmaceutical (WST) Exceeds Market Expectations with Stron - GuruFocus
West Pharmaceutical Services, Inc. $WST Shares Sold by ING Groep NV - MarketBeat
West Pharma (WST) Q4 2025 Earnings Call Transcript - The Globe and Mail
West Pharmaceutical Services Posts Solid Q4 and 2025 Results - TipRanks
West Pharmaceutical (WST) Exceeds Revenue Expectations in Q4 - GuruFocus
West Pharmaceutical Services (WST) Projects FY26 Revenue Range - GuruFocus
Q4 Earnings Update: IRM, USFD, and WST Post Solid Q4 Results - Tokenist
Form 8-K WEST PHARMACEUTICAL SERV For: Feb 12 - StreetInsider
West Pharmaceutical Q4 EPS Beats Estimates; Guides 2026 Sales Growth of 5% to 7% - AlphaStreet News
West Pharmaceutical Services (WST) Tops Q4 Earnings and Revenue Estimates - Yahoo Finance
West Pharmaceutical: Q4 Earnings Snapshot - kare11.com
West Pharmaceutical Servs Q4 Earnings Summary & Key Takeaways - Benzinga
WEST PHARMACEUTICAL SVSC ($WST) Releases Q4 2025 Earnings - Quiver Quantitative
West Pharma shares climb over 5% on strong fourth-quarter results - Investing.com UK
West Pharma shares climb over 5% on strong fourth-quarter results By Investing.com - Investing.com Nigeria
West Pharmaceutical: Q4 Financial Results Overview - Bitget
(WST) West Pharmaceutical Services, Inc. Expects Q1 Adjusted EPS Range $1.65$1.70 - marketscreener.com
West Pharmaceutical Services earnings beat by $0.20, revenue topped estimates - Investing.com Canada
West Pharmaceutical Services’s (NYSE:WST) Q4 CY2025: Beats On Revenue, Stock Soars - Yahoo Finance
(WST) West Pharmaceutical Expects 2026 Net Sales Range $3.22B to $3.28B, vs. FactSet Est of $3.24B - marketscreener.com
West Reports Fourth-Quarter and Full-Year 2025 Results – Company Announcement - Financial Times
Is West Pharmaceutical Services (NYSE:WST) a Pillar In S&P 500 Futures Performance - Kalkine Media
West Pharmaceutical faces earnings test as estimates drift lower By Investing.com - Investing.com Canada
Evaluating West Pharmaceutical Services (WST) Valuation As Earnings And GLP 1 Growth Stay In Focus - Sahm
West Pharmaceutical Services, Inc. (NYSE:WST) Receives Average Rating of "Buy" from Brokerages - MarketBeat
West Pharmaceutical Services Earnings Preview: Analysts Project $793.4M RevenueNews and Statistics - IndexBox
West Pharmaceutical Services Earnings: What To Look For From WST - Finviz
West Pharmaceutical Services Inc (WST)'s Winning Formula: Financ - GuruFocus
Countdown to West Pharmaceutical (WST) Q4 Earnings: A Look at Estimates Beyond Revenue and EPS - Yahoo Finance
Jefferies Adjusts Price Target on West Pharmaceutical Services to $295 From $365, Maintains Buy Rating - marketscreener.com
Rockland Trust Co. Buys 5,087 Shares of West Pharmaceutical Services, Inc. $WST - MarketBeat
WST Q4 Earnings Preview: Can HVP Momentum Continue to Drive Margins? - TradingView
Envestnet Asset Management Inc. Cuts Position in West Pharmaceutical Services, Inc. $WST - MarketBeat
Why The Narrative Around West Pharmaceutical Services (WST) Is Shifting After New Valuation Updates - Yahoo Finance
West Pharmaceutical Services, Inc. (WST): A Bull Case Theory - Insider Monkey
West Pharmaceutical Services Inc. stock outperforms competitors on strong trading day - MSN
West Pharmaceutical Services Unveils “Synchrony S1” Syringe System to Speed Drug Packaging Development - MarketBeat
West Pharmaceutical Services Inc (WST) Trading 5.8% Higher on Fe - GuruFocus
West Pharmaceutical Services stock: Is WST underperforming the healthcare sector? - MSN
0.17%
0.53%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):